37. When patients are receiving anticoagulants, health care professionals should monitor for which of the following adverse effects?
Answer: B
Health care professionals should monitor for hemorrhage when patients are receiving anticoagulants.
Anticoagulants are medications that help prevent blood clots, but they also increase the risk of bleeding. Therefore, monitoring for hemorrhage is crucial for patients on these medications.
A) anuria.
Anuria, or the absence of urine production, is not a direct adverse effect associated with anticoagulant therapy. While renal function should be monitored, anuria is not a common concern linked to anticoagulants.
B) hemorrhage.
Hemorrhage is a significant risk associated with anticoagulant therapy due to the drugs' blood-thinning effects. Health care professionals must vigilantly monitor patients for signs of bleeding, including unusual bruising, blood in urine or stool, and prolonged bleeding from cuts.
C) musculoskeletal pain.
Musculoskeletal pain is not typically a direct adverse effect of anticoagulants. While patients may experience pain for various reasons, it is not a primary concern that necessitates monitoring in patients receiving these medications.
D) polyuria.
Polyuria, or excessive urination, is not a known adverse effect of anticoagulants. This condition is generally unrelated to anticoagulant use and does not require specific monitoring in this context.
Conclusion
Monitoring for hemorrhage is essential when patients are on anticoagulants due to the heightened risk of bleeding. Other options, including anuria, musculoskeletal pain, and polyuria, do not represent the primary concerns linked to anticoagulant therapy, making them less relevant in this context. Thus, option B is the appropriate choice for monitoring adverse effects in these patients.